Sign in
Not yet recruitingPhase 4

Intranasal Dexmedetomidine or Esketamine for Negative Postoperative Behavioral Changes in Children

Key facts

Who runs it
Nanjing Children's Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 4
People taking part
342 people, planned
Started
1 Jun 2026
Expected to end
30 Nov 2027
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Dexmedetomidine
  • Esketamine
  • Normal Saline
Record updated
6 May 2026

Who can take part

Age
2 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Children aged 2 to 12 years
  • Scheduled to undergo elective day surgery under general anesthesia
  • ASA (American Society of Anesthesiologists) physical status I to III

Who cannot take part

  • Severe upper respiratory tract infections prior to surgery
  • Use of sedatives or analgesics within 48 hours before surgery
  • Exposure to major life stressors within 1 month before surgery (e.g., family separation, death of a parent)
  • Congenital diseases or severe liver or kidney dysfunction
  • History of allergic reactions to study drugs
  • Neuromuscular diseases, cerebral palsy, epilepsy
  • Other psychiatric or neurological disorders
  • Refusal to participate or failure to obtain consent from the child's legal guardian
  • Body mass index (BMI) ≥ 30 kg/m²

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 2 and 12 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn whether intranasal dexmedetomidine or esketamine given before anesthesia can reduce negative postoperative behavioral changes in children undergoing day surgery. Negative postoperative behavioral changes may include anxiety, sleep problems, nightmares, irritability, or other unusual behaviors after surgery. This study will also examine whether changes in brain wave patterns during the perioperative period are related to these behavioral changes.

Read full original descriptionShow less

The main questions this study aims to answer are:

Does intranasal dexmedetomidine reduce negative postoperative behavioral changes in children after day surgery? Does intranasal esketamine reduce negative postoperative behavioral changes in children after day surgery? Are perioperative electroencephalographic (EEG) features associated with negative postoperative behavioral changes? Researchers will compare intranasal dexmedetomidine, intranasal esketamine, and normal saline to see whether these treatments differ in their effects on postoperative behavior and perioperative EEG features.

Participants will be randomly assigned to receive intranasal dexmedetomidine, intranasal esketamine, or intranasal normal saline about 30 minutes before anesthesia. They will receive routine perioperative monitoring, including EEG monitoring during surgery and recovery. They will also be assessed for sedation, pain, and emergence delirium. Follow-up assessments of postoperative behavioral changes will be completed on postoperative days 3, 7, and 28.

The 3 groups in the trial

  • Intranasal DexmedetomidineTreatment being tested

    Participants receive intranasal dexmedetomidine 2.0 micrograms/kg approximately 30 minutes before induction of general anesthesia.

    Treatment: Dexmedetomidine

  • Intranasal EsketamineTreatment being tested

    Participants receive intranasal esketamine 1.0 mg/kg approximately 30 minutes before induction of general anesthesia.

    Treatment: Esketamine

  • Normal Saline ControlPlacebo, for comparison

    Participants receive an equal volume of intranasal normal saline approximately 30 minutes before induction of general anesthesia.

    Treatment: Normal Saline

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exploring the Association of Perioperative Electroencephalographic Changes Following Preoperative Intranasal Dexmedetomidine or Esketamine With Negative Postoperative Behavioral Changes in Children Undergoing Day Surgery
Criteria questions
Built from NCT07570160, who can take part
Record updated
6 May 2026